![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rtkn2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RTKN2 mRNA | CTD | PMID:22079256 | Rtkn2 | Rat | 1,2-dichloroethane | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of RTKN2 mRNA | CTD | PMID:28960355 | Rtkn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RTKN2 mRNA | CTD | PMID:32109520 | Rtkn2 | Rat | 2,5-hexanedione | increases expression | EXP | | 6480464 | 2 and 5-hexanedione results in increased expression of RTKN2 mRNA | CTD | PMID:22952946 | Rtkn2 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RTKN2 mRNA | CTD | PMID:24780913 | Rtkn2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of RTKN2 mRNA | CTD | PMID:25825206 | Rtkn2 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of RTKN2 mRNA | CTD | PMID:31881176 | Rtkn2 | Rat | acrylamide | increases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Acrylamide results in increased expression of RTKN2 mRNA | CTD | PMID:30807115 | Rtkn2 | Rat | aflatoxin B1 | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of RTKN2 mRNA | CTD | PMID:21641981 | Rtkn2 | Rat | aflatoxin M1 | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of RTKN2 mRNA | CTD | PMID:30928695 | Rtkn2 | Rat | all-trans-retinoic acid | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of RTKN2 mRNA | CTD | PMID:33167477 | Rtkn2 | Rat | arsane | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA | CTD | PMID:39836092 | Rtkn2 | Rat | arsenic atom | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA | CTD | PMID:39836092 | Rtkn2 | Rat | benzo[a]pyrene | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of RTKN2 mRNA | CTD | PMID:21632981 | Rtkn2 | Rat | benzo[e]pyrene | decreases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of RTKN2 intron | CTD | PMID:30157460 | Rtkn2 | Rat | beta-lapachone | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of RTKN2 mRNA | CTD | PMID:38218311 | Rtkn2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of RTKN2 mRNA | CTD | PMID:32235866 | Rtkn2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RTKN2 mRNA | CTD | PMID:25181051 and PMID:34947998 | Rtkn2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of RTKN2 gene | CTD | PMID:28505145 | Rtkn2 | Rat | butanal | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of RTKN2 mRNA | CTD | PMID:26079696 | Rtkn2 | Rat | cadmium dichloride | increases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of RTKN2 mRNA | CTD | PMID:38568856 | Rtkn2 | Rat | calcitriol | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of RTKN2 mRNA | CTD | PMID:21592394 | Rtkn2 | Rat | calcitriol | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA | CTD | PMID:21592394 | Rtkn2 | Rat | carbon nanotube | affects expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of RTKN2 mRNA | CTD | PMID:25554681 | Rtkn2 | Rat | carbon nanotube | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of RTKN2 mRNA | CTD | PMID:25554681 | Rtkn2 | Rat | CGP 52608 | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RTKN2 gene] | CTD | PMID:28238834 | Rtkn2 | Rat | chlorpyrifos | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of RTKN2 mRNA | CTD | PMID:37019170 | Rtkn2 | Rat | chromium(6+) | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of RTKN2 mRNA | CTD | PMID:30690063 | Rtkn2 | Rat | copper(II) sulfate | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RTKN2 mRNA | CTD | PMID:19549813 | Rtkn2 | Rat | dicrotophos | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of RTKN2 mRNA | CTD | PMID:28302478 | Rtkn2 | Rat | dioxygen | multiple interactions | ISO | Rtkn2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTKN2 mRNA | CTD | PMID:30529165 | Rtkn2 | Rat | dorsomorphin | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA | CTD | PMID:27188386 | Rtkn2 | Rat | fonofos | increases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of RTKN2 promoter | CTD | PMID:22847954 | Rtkn2 | Rat | glyphosate | increases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Glyphosate results in increased expression of RTKN2 mRNA | CTD | PMID:35897073 | Rtkn2 | Rat | leflunomide | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of RTKN2 mRNA | CTD | PMID:28988120 | Rtkn2 | Rat | manganese atom | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA | CTD | PMID:39836092 | Rtkn2 | Rat | manganese(0) | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA | CTD | PMID:39836092 | Rtkn2 | Rat | manganese(II) chloride | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA | CTD | PMID:39836092 | Rtkn2 | Rat | methamphetamine | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Methamphetamine results in decreased expression of RTKN2 mRNA | CTD | PMID:26307267 | Rtkn2 | Rat | methapyrilene | decreases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of RTKN2 intron | CTD | PMID:30157460 | Rtkn2 | Rat | methotrexate | increases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of RTKN2 mRNA | CTD | PMID:24449571 | Rtkn2 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of RTKN2 gene | CTD | PMID:35440735 | Rtkn2 | Rat | methylmercury chloride | increases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of RTKN2 mRNA | CTD | PMID:23179753 | Rtkn2 | Rat | N-Nitrosopyrrolidine | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of RTKN2 mRNA | CTD | PMID:32234424 | Rtkn2 | Rat | nickel atom | increases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Nickel results in increased expression of RTKN2 mRNA | CTD | PMID:24768652 and PMID:25583101 | Rtkn2 | Rat | ozone | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | Ozone results in decreased expression of RTKN2 mRNA | CTD | PMID:17095637 | Rtkn2 | Rat | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of RTKN2 mRNA | CTD | PMID:28623178 | Rtkn2 | Rat | paracetamol | increases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of RTKN2 mRNA | CTD | PMID:22230336 | Rtkn2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RTKN2 mRNA | CTD | PMID:33387578 | Rtkn2 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of RTKN2 mRNA | CTD | PMID:32680482 | Rtkn2 | Rat | parathion | increases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | Parathion results in increased methylation of RTKN2 promoter | CTD | PMID:22847954 | Rtkn2 | Rat | perfluorooctanoic acid | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of RTKN2 mRNA | CTD | PMID:36326898 | Rtkn2 | Rat | phenethyl isothiocyanate | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | phenethyl isothiocyanate results in decreased expression of RTKN2 mRNA | CTD | PMID:26678675 | Rtkn2 | Rat | pirinixic acid | increases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of RTKN2 mRNA | CTD | PMID:20813756 | Rtkn2 | Rat | potassium chromate | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RTKN2 mRNA | CTD | PMID:22079256 | Rtkn2 | Rat | potassium chromate | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of RTKN2 mRNA | CTD | PMID:22079256 and PMID:22714537 | Rtkn2 | Rat | SB 431542 | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA | CTD | PMID:27188386 | Rtkn2 | Rat | silicon dioxide | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of RTKN2 mRNA | CTD | PMID:25895662 | Rtkn2 | Rat | sodium arsenite | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA | CTD | PMID:39836092 | Rtkn2 | Rat | sunitinib | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of RTKN2 mRNA | CTD | PMID:31533062 | Rtkn2 | Rat | terbufos | increases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | terbufos results in increased methylation of RTKN2 promoter | CTD | PMID:22847954 | Rtkn2 | Rat | testosterone | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA | CTD | PMID:21592394 | Rtkn2 | Rat | testosterone | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of RTKN2 mRNA | CTD | PMID:21592394 | Rtkn2 | Rat | titanium dioxide | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of RTKN2 mRNA | CTD | PMID:23557971 | Rtkn2 | Rat | titanium dioxide | increases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | titanium dioxide results in increased methylation of RTKN2 promoter | CTD | PMID:34973136 | Rtkn2 | Rat | titanium dioxide | decreases methylation | ISO | Rtkn2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of RTKN2 gene | CTD | PMID:35295148 | Rtkn2 | Rat | titanium dioxide | increases methylation | ISO | Rtkn2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of RTKN2 promoter | CTD | PMID:35295148 | Rtkn2 | Rat | trichostatin A | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of RTKN2 mRNA | CTD | PMID:26272509 | Rtkn2 | Rat | trichostatin A | affects expression | ISO | RTKN2 (Homo sapiens) | 6480464 | trichostatin A affects the expression of RTKN2 mRNA | CTD | PMID:28542535 | Rtkn2 | Rat | trichostatin A | multiple interactions | ISO | RTKN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA | CTD | PMID:27188386 | Rtkn2 | Rat | triphenyl phosphate | affects expression | ISO | RTKN2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of RTKN2 mRNA | CTD | PMID:37042841 | Rtkn2 | Rat | triptonide | increases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | triptonide results in increased expression of RTKN2 mRNA | CTD | PMID:33045310 | Rtkn2 | Rat | trovafloxacin | decreases expression | ISO | Rtkn2 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of RTKN2 mRNA | CTD | PMID:35537566 | Rtkn2 | Rat | valproic acid | decreases methylation | ISO | RTKN2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of RTKN2 gene | CTD | PMID:29154799 | Rtkn2 | Rat | valproic acid | decreases expression | ISO | RTKN2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RTKN2 mRNA | CTD | PMID:23179753 more ... | Rtkn2 | Rat | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of RTKN2 gene | CTD | PMID:31682807 | |